CAS
MRNS

Coppell Advisory Solutions’s Marinus Pharmaceuticals, Inc MRNS Stock Holding History

Coppell Advisory Solutions’s Portfolio MRNS Stock Details MRNS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-3,092
Closed -$31.4K – 1988
2024
Q4 		$31.4K Hold
3,092
– – ﹤0.01% 727
2024
Q3 		$31.4K Hold
3,092
– – ﹤0.01% 696
2024
Q2 		$31.4K Buy
+3,092
New +$7.74K 0.01% 621
2023
Q4 		$54.2K Buy
+4,984
New +$37.4K 0.01% 473

Coppell Advisory Solutions's MRNS Position: Q1 2025 in Review

Coppell Advisory Solutions sold out of Marinus Pharmaceuticals, Inc (MRNS) in Q1 2025, closing a stake of 3,092 shares — an estimated $31.4K sold.

Coppell Advisory Solutions first reported a position in MRNS in Q4 2023 and held it in 4 quarters. The position peaked at $54.2K in Q4 2023. 0 funds tracked by Wall St. Rank hold MRNS as of Q1 2025.

  • Coppell Advisory Solutions reported no remaining Marinus Pharmaceuticals, Inc position as of Q1 2025 after selling out during the quarter.
  • Coppell Advisory Solutions sold 3,092 Marinus Pharmaceuticals, Inc shares in Q1 2025, an estimated $31.4K.
  • Coppell Advisory Solutions first reported a position in Marinus Pharmaceuticals, Inc in Q4 2023 and held it in 4 quarters.
  • Coppell Advisory Solutions's Marinus Pharmaceuticals, Inc position peaked at $54.2K in Q4 2023.
  • 0 funds tracked by Wall St. Rank held Marinus Pharmaceuticals, Inc as of Q1 2025.

Based on Coppell Advisory Solutions's 13F filing for Q1 2025, filed 16 May 2025.